Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
apratastat tnf alpha converting enzyme NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Rheumatoid Arthritis[MeSHID:D001172]		 7.07 phase 2 unknown
apratastat tnf alpha converting enzyme NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Rheumatoid Arthritis[MeSHID:D001172]		 7.07 phase 2 inhibitor
apratastat matrix metalloproteinase-1 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Rheumatoid Arthritis[MeSHID:D001172]		 2.12 phase 2 unknown
apratastat matrix metalloproteinase-1 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Rheumatoid Arthritis[MeSHID:D001172]		 2.12 phase 2 inhibitor
apratastat matrix metalloproteinase-13 NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Rheumatoid Arthritis[MeSHID:D001172]		 6.06 phase 2 unknown
apratastat matrix metalloproteinase-13 NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Rheumatoid Arthritis[MeSHID:D001172]		 6.06 phase 2 inhibitor
click here to return to the previous page